Clinical Report: Colorectal Cancer Emergencies in Older Adults
Overview
This review highlights the significant incidence of colorectal cancer emergencies in patients aged ≥80 years, with up to 46% presenting in emergency situations. Key findings indicate that frailty and comorbidity are critical factors influencing outcomes, and that bridge-to-surgery strategies can reduce early mortality.
Background
The aging global population is leading to an increase in colorectal cancer (CRC) cases among very elderly individuals, who often present with advanced disease and multiple comorbidities. Emergency presentations, such as malignant bowel obstruction, are common and associated with poorer survival outcomes. Effective management requires a balance between oncologic treatment and geriatric care principles.
Data Highlights
Replace with actual data or a statement indicating the absence of specific numerical data.
Key Findings
Emergency CRC presentation occurs in up to 46% of colon cancers in patients aged ≥80 years.
Malignant bowel obstruction is the most frequent emergency scenario in this population.
Bridge-to-surgery strategies, such as self-expanding metal stents (SEMS), significantly reduce early mortality compared to emergency resection.
Frailty and comorbidity burden are major independent prognostic factors affecting outcomes.
Damage-control approaches are essential for managing perforation and septic complications.
Future research should focus on frailty-based triage models and geriatric-specific endpoints.
Clinical Implications
Healthcare providers must adopt a patient-centered approach when managing CRC emergencies in elderly patients, considering both oncologic and geriatric factors. Implementing bridge-to-surgery strategies may improve outcomes for selected patients, while recognizing the importance of frailty and comorbidity in treatment planning.
Conclusion
Colorectal cancer emergencies in patients aged ≥80 years require a nuanced approach that integrates oncologic care with geriatric considerations. Ongoing research is essential to refine management strategies tailored to this vulnerable population.
A systematic review and meta-analysis found that early time-of-day immunotherapy was associated with improved survival outcomes in patients with advanced cancers, with the association appearing to be ...
In the final analysis of the phase III EORTC 1333/PEACE-3 trial, with a median follow-up of 58 months, the addition of radium-223 to the androgen receptor inhibitor enzalutamide significantly prolonge...
Each year, globally, about 400,000 children and adolescents aged between 0 and 19 years are diagnosed with cancer; over 100,000 die from the disease, with most of those cases, over 80%, and deaths occ...
